Demant A/S

Demant A/S EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Demant A/S (DEMANT.CO) as of Nov 22, 2026 is 11.08. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 8.73 — a change of 26.83% (higher).

EV/EBITDA

11.08

YoY

26.83%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Demant A/S is 2025 11.08 . EV/EBITDA (Enterprise Value to EBITDA) of Demant A/S was 2024 8.73 . It decreases by 26.83% higher compared to the previous year.

The Demant A/S EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
16.87 DKK
Jan 1, 2019
20.17 DKK
Jan 1, 2020
21.14 DKK
Jan 1, 2021
13.14 DKK
Jan 1, 2022
12.15 DKK
Jan 1, 2023
9.63 DKK
Jan 1, 2024
8.73 DKK
Jan 1, 2025
11.08 DKK
The Demant A/S EV/EBITDA history
YEAREV/EBITDAYoY
11.08+26.83%
8.73-9.31%
9.63-20.71%
12.15-7.59%
13.14-37.82%
21.14+4.79%
20.17+19.54%
16.87-4.15%
17.61-16.67%
21.13+5.09%
20.11-3.77%
20.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Demant A/S Stock analysis

What does Demant A/S do? Demant A/S is a Danish company that operates in the field of hearing technology. It was founded in 1904 and is headquartered in Smørum, Denmark. The company has several subsidiaries in various countries, including the USA, Germany, France, and China. The history of Demant began with the founding of the company Oticon by Hans Demant in Copenhagen in 1904. Oticon was the first company to manufacture and sell hearing aids. Since then, the company has evolved into a leading provider of hearing aids, cochlear implants, and assistive listening devices. Demant's business model is based on the development and marketing of hearing technology products. The company is divided into several business areas, including hearing aids, cochlear implants, and diagnostics and consumables. In the field of hearing aids, Demant offers a wide range of products tailored to the needs of different customer groups. These range from basic hearing aids to high-end products with artificial intelligence. Demant's cochlear implant system is a groundbreaking technology that enables deaf or hard-of-hearing individuals to hear. It consists of an implanted device and an external speech processor. Demant's diagnostics and consumables business includes a variety of products used by medical professionals for the diagnosis and treatment of hearing disorders. These include earplugs, audiometry devices, tympanometry devices, and others. Demant is also active in many other areas, including research, development, and production of hearing technology products. The company has a strong global network of partners, distributors, and customers that further strengthens its position as a leading provider of hearing technology products. Overall, Demant has developed a deep understanding of the needs and requirements of people with hearing problems through its commitment to excellence and innovation. With its wide range of products, global network, and deep commitment to customer satisfaction, Demant has become a trusted name in hearing technology. Demant A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Demant A/S stock

EV/EBITDA (Enterprise Value to EBITDA) of Demant A/S is 11.08 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Demant A/S changed from 8.73 to 11.08, representing a 26.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Demant A/S since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Demant A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Demant A/S

All Key Metrics — Demant A/S